RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual MeetingBusiness Wire • 11/11/21
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic CancerBusiness Wire • 11/09/21
RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher TodayInvestorPlace • 09/07/21
RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid TumorsPRNewsWire • 09/07/21